Martin D. Madaus

Martin Madaus is an accomplished leader in the life sciences sector, currently serving as a Member of the Board of Directors at Azenta Life Sciences and a Director at Repligen Corporation and Unchained Labs. With extensive experience in advisory roles, Madaus is an Advisor at The Carlyle Group and holds the position of Executive Chairman at Emulate Bio. Notably, Madaus has been the Chairman of the Board at Quanterix since 2010, contributing to the development of innovative detection technologies. Previous leadership roles include Executive Chairman at Ultivue, Strategic Advisor at Sherlock Biosciences, and Chairman and CEO of Ortho Clinical Diagnostics. Madaus holds a Ph.D. in Veterinary Medicine from Tierärztliche Hochschule Hannover and a Doctor of Veterinary Medicine from Ludwig-Maximilians-Universität München.